NCT07284914

Brief Summary

This research project aims to test the effect of two interventions targeted to community pharmacies in the Greater Accra region, Ghana, on antibiotics dispensing rates. The general goal is to inform the design of future policies to address the rising threat of antimicrobial resistance.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
285

participants targeted

Target at P75+ for not_applicable

Timeline
7mo left

Started Apr 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Apr 2026Dec 2026

First Submitted

Initial submission to the registry

December 3, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 16, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

December 16, 2025

Status Verified

December 1, 2025

Enrollment Period

4 months

First QC Date

December 3, 2025

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Non-prescription antibiotics dispensing rate

    Whether the pharmacy dispenses antibiotics without prescription in scenarios not requiring them

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

Secondary Outcomes (5)

  • Watch or reserve antibiotics

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

  • Out-of-pocket costs to patients

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

  • Referral to a physician

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

  • History taking

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

  • Interaction time

    From baseline (1st SP visit) to the final SP visit (visit 5), lasting approximately 5 months.

Study Arms (3)

Control

NO INTERVENTION

No intervention

Individualized Feedback

EXPERIMENTAL

Pharmacies receive customized feedback on their antibiotics dispensing behavior.

Behavioral: Individualized Feedback

Legal Reminder

EXPERIMENTAL

Pharmacies receive letter from the authorities in Ghana emphasizing that providing antibiotics without a physician prescription is against the law.

Behavioral: Legal Reminder

Interventions

Legal ReminderBEHAVIORAL

We provide a letter from the authorities in Ghana emphasizing that providing antibiotics without a physician prescription is against the law.

Legal Reminder

We use information from the baseline visits (e.g., on whether they give antibiotics without a prescription and the time they spend with patients) to provide customized feedback to the pharmacies.

Individualized Feedback

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Operating within the Greater Accra region of Ghana
  • Registered with Ghana Pharmacy Council
  • "Stand-alone", i.e., not affiliated or next to a hospital

You may not qualify if:

  • Operating only outside the Greater Accra region of Ghana
  • Not registered with Ghana Pharmacy Council
  • Hospital pharmacy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ghana, Regional Institute for Population Studies

Legon, Ghana

Location

MeSH Terms

Conditions

Respiratory Tract Infections

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract Diseases

Central Study Contacts

Yubraj Acharya, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: Community pharmacies will be randomized into 3 arms (control, Individualized Feedback, and Legal Reminder). Pharmacies in each arm will be visited by standardized patients under 4 scenarios (low demand-young patient; low demand-old patient, normal demand-young patient, normal demand-old patient).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 3, 2025

First Posted

December 16, 2025

Study Start

April 1, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

December 16, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations